4.7 Article

HPDL deficiency causes a neuromuscular disease by impairing the mitochondrial respiration

Journal

JOURNAL OF GENETICS AND GENOMICS
Volume 48, Issue 8, Pages 727-736

Publisher

SCIENCE PRESS
DOI: 10.1016/j.jgg.2021.01.009

Keywords

HPDL gene; Mitochondrial disease; Respiration impairment; OXPHOS; Respiration chain complex II

Funding

  1. Precision Medical Research of National Key Research and Development Program [2018YFC1002200, 2019YFC1005100, 2018YFC1002400, 2018YFC1002501]
  2. National Natural Science Foundation of China [81873633, 82071276, 81830071, 81873724, 82070914, 81873671]
  3. Shanghai Science and Technology Commission [19140904500]
  4. Jiaotong University Cross Biomedical Engineering [YG2017MS72]
  5. Eastern Scholar Fund
  6. Guangxi Bagui Scholar fund
  7. Major Research Plan of the Provincial Science and Technology Foundation of Guangxi [AB16380214]
  8. Foundation of Shanghai Municipal Health Commission [shslczdzk05702]
  9. Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20191908]
  10. Shanghai Shen Kang Hospital Development Center [SHDC12017109]

Ask authors/readers for more resources

Mitochondrial diseases caused by variants in HPDL gene can result in impaired mitochondrial respiratory function and dysfunction of OXPHOS complex II. The study found that bi-allelic inactivations of HPDL lead to neurodegenerative disease characterized by pediatric-onset spastic movement phenotypes, expanding the understanding of mitochondrial neuropathy mechanisms.
Mitochondrial diseases are caused by variants in both mitochondrial and nuclear genomes. A nuclear gene HPDL (4-hydroxyphenylpyruvate dioxygenase-like), which encodes an intermembrane mitochondria! protein, has been recently implicated in causing a neurodegenerative disease characterized by pediatric-onset spastic movement phenotypes. Here, we report six Chinese patients with bi-allelic HPDL pathogenic variants from four unrelated families showing neuropathic symptoms of variable severity, including developmental delay/intellectual disability, spasm, and hypertonia. Seven different pathogenic variants are identified, of which five are novel. Both fibroblasts and immortalized lymphocytes derived from patients show impaired mitochondrial respiratory function, which is also observed in HPDL-knockdown (KD) HeLa cells. In these HeLa cells, overexpression of a wild-type HPDL gene can rescue the respiratory phenotype of oxygen consumption rate. In addition, a decreased activity of the oxidative phosphorylation (OXPHOS) complex II is observed in patient-derived lymphocytes and HPDL KD HeLa cells, further supporting an essential role of HPDL in the mitochondrial respiratory chain. Collectively, our data expand the clinical and mutational spectra of this mitochondrial neuropathy and further delineate the possible disease mechanism involving the impairment of the OXPHOS complex II activity due to the bi-allelic inactivations of HPDL. Copyright (C) 2021, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available